Abstract:Elaborate regulation of innate immunity is necessary for the host to effectively respond to invading pathogens. As an important component of antiviral immunity transcription factors, the stability and activity of interferon (IFN) regulatory factor 3 (IRF3) are tightly controlled via multiple post-translational modifications. Here, we identified a human ovarian tumor domain-containing deubiquitinase OTUD6B as a positive regulator of IRF3 that facilitates type I IFN innate antiviral immune signaling. Mechanically, we found that OTUD6B interacts with IRF3 and directly hydrolyzes both the lysine 11 (K11)- and the lysine 33 (K33)-linked polyubiquitin chain, but only K33-linked polyubiquitin at Lys315 of IRF3 is responsible for IRF3 proteasome degradation. Notably, OTUD6B enhanced cellular antiviral responses in vivo, as evidenced by mice that overexpressed human OTUD6B were more resistant to RNA virus infection and had reduced viral load and morbidity. These findings revealed a previously unknown role for OTUD6B in the regulation of innate antiviral immunity and may provide a potential target for enhancing host antiviral defense.IMPORTANCE Interferon (IFN) regulatory factor (IRF3) is one of the key factors for type I IFN transcription. To sophisticatedly regulate type I IFN antiviral immune response, IRF3 activity is closely controlled by a variety of post-translational modifications. However, the regulatory mechanisms are still not fully elucidated. In the present study, we found that human deubiquitinase OTUD6B positively regulates IRF3-mediated antiviral immune response. OTUD6B can stabilize the IRF3 protein level via hydrolyzing (Lys33)-linked polyubiquitin at Lys315. More importantly, mice with OTUD6B overexpression exhibited more resistance to RNA virus infection. Thus, unlike the previous report that zebrafish OTUD6B negatively regulates the antiviral response by suppressing K63-linked ubiquitination of IRF3 and IRF7, we demonstrate that human OTUD6B actually enhances type I IFN response and has the potential for antiviral therapy.

Human DUBs' Gene Expression and Regulation in Antiviral Signaling in Response to Poly (I:C) Treatment.

An Integrated View of Deubiquitinating Enzymes Involved in Type I Interferon Signaling, Host Defense and Antiviral Activities

Cellular Deubiquitylating Enzyme: A Regulatory Factor of Antiviral Innate Immunity

The Functional Deubiquitinating Enzymes in Control of Innate Antiviral Immunity

The Role of Deubiquitinases in Virus Replication and Host Innate Immune Response

A Deubiquitinase That Regulates Type I Interferon Production

Ubiquitin C-terminal Hydrolase-L3 Promotes Interferon Antiviral Activity by Stabilizing Type I-interferon Receptor.

Deubiquitinase USP47 attenuates virus-induced type I interferon signaling

Regulation of Virus-triggered Signaling by OTUB1- and OTUB2-mediated Deubiquitination of TRAF3 and TRAF6

Fine-tuning of antiviral innate immunity by ubiquitination

Broad and diverse mechanisms used by deubiquitinase family members in regulating the type I interferon signaling pathway during antiviral responses

Human OTUD6B Positively Regulates Type I IFN Antiviral Innate Immune Responses by Deubiquitinating and Stabilizing IRF3.

Specific Deubiquitinating Enzymes Promote Host Restriction Factors Against Hiv/Siv Viruses

Viral deubiquitinases and innate antiviral immune response in livestock and poultry

Regulation of cellular innate antiviral signaling by ubiquitin modification.

Regulation of Antiviral Innate Immunity by Deubiquitinase Cyld

Regulation of Innate Antiviral Immunity by Protein Ubiquitination

Ubiquitin-Specific Protease 13 Regulates IFN Signaling by Stabilizing STAT1

DDX4 enhances antiviral activity of type I interferon by disrupting interaction of USP7/SOCS1 and promoting degradation of SOCS1

The Role of Deubiquitinases in Oncovirus and Host Interactions

Ubiquitin-specific Protease 15 Negatively Regulates Virus-induced Type I Interferon Signaling via Catalytically-dependent and -independent Mechanisms